David Huntsman MD, FRCPC, FCCMG
Chief Medical Officer
Dr. Huntsman’s expertise is in the translation of genomics into assays leading into improved cancer control, which demands complementary expertise in the development and delivery of novel assays as well as discovery genomics. In addition to leading cutting-edge research in the discovery and development of biomarkers and therapeutic targets for ovarian and rare cancers, Dr. Huntsman leads British Columbia’s multidisciplinary ovarian cancer research team. Dr. Huntsman’s group has a long track record of taking discoveries from basic genomic research into large cohorts of clinically annotated samples to determine their clinical relevance followed by clinical implementation.
- Select Publications